This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on Web of Science (22)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

James R. Gillette, PhD

Arch Intern Med. 1981;141(3):375-379.

Abstract
• I have examined in mice the kinetics of covalent binding of a metabolite of acetaminophen, as well as the binding to target tissue (and hence toxic reactions). At low doses, the chemically reactive metabolite seems to be converted to a glutathione conjugate that is ultimately excreted as a mercapturic acid. High acetaminophen doses that deplete available glutathione in the liver lead to toxic reactions. Manipulation of the system with agents that affect either glutathione availability or activity of the operative enzyme system has suggested that a chemically reactive acetaminophen metabolite is the active agent in hepatotoxic reactions from the drug. The chemically reactive intermediate seems to be short lived; it reacts with glutathione and is easily reduced by ascorbic acid. Acetylcysteine prevents liver necrosis caused by acetaminophen, and some possible mechanisms are discussed.

(Arch Intern Med 1981;141:375-379)

Author Affiliations
From the Laboratory of Chemical Pharmacology, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Md.

Footnotes
Reprint requests to Laboratory of Chemical Pharmacology, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD 20205 (Dr Gillette).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?